This article is more than 5 years old. Information may no longer be current.

NearVision CK corrects presbyopia after LASIK in early trial results

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Conductive keratoplasty for the treatment of presbyopia in patients with previous LASIK has shown an “excellent safety profile” in 23 patients with 1 month follow-up, according to Daniel S. Durrie, MD.

Dr. Durrie presented results of a phase 3 multicenter trial of 150 patients with previous LASIK who underwent NearVision CK (Refractec) for the correction of presbyopia. Dr. Durrie presented his results at a press briefing during the American Academy of Ophthalmology meeting.

The first 23 patients showed no flap complications or adverse events at the 1 month follow-up, according to a press release from Refractec. In addition, 96% could read J3 or better, and 96% achieved binocular intermediate vision of 20/20 or better. Preoperatively, 65% of patients achieved that level of visual acuity.

All patients achieved binocular uncorrected visual acuity (UCVA) of 20/25 or better at distance and more than 90% achieved binocular uncorrected near vision allowing them to read J2-sized print or smaller.

NearVision CK is approved in the United States for the treatment of presbyopia and hyperopia; Refractec is seeking to expand approval to include near vision improvement in post-LASIK patients, according to the press release.

Refractec also announced the launch of a study of NearVision CK with LightTouch during the AAO meeting. According to the company, the LightTouch technique “enhances the absorption of the radiofrequency energy” in CK.